CANCER GENETICS, INC Uncategorized Contracts & Agreements
31 Contracts & Agreements
- Description of Securities (Filed With SEC on March 31, 2023)
- Description of Securities (Filed With SEC on March 30, 2022)
- Description of Securities (Filed With SEC on March 31, 2021)
- Form of Engagement Agreement, dated September 18, 2020, as amended (Filed With SEC on February 16, 2021)
- Form of Wainwright Warrants dated February 16, 2021 (Filed With SEC on February 16, 2021)
- Form of Placement Agent Warrants (Filed With SEC on February 1, 2021)
- At The Market Offering Agreement by and between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC, dated December 2, 2020 (Filed With SEC on December 3, 2020)
- Form of Underwriter Warrants of Cancer Genetics, Inc (Filed With SEC on November 2, 2020)
- Description of Securities (Filed With SEC on May 29, 2020)
- Standstill Agreement #2, between Iliad Research and Trading, L.P. and Cancer Genetics, Inc., dated May 3, 2019 (Filed With SEC on May 20, 2019)
- Offer Letter with William Finger, dated December 14, 2018 (Filed With SEC on April 16, 2019)
- Offer Letter with Michael McCartney, dated May 14, 2018 (Filed With SEC on April 16, 2019)
- Standstill Agreement, between Iliad Research and Trading, L.P. and Cancer Genetics, Inc., dated February 12, 2019 (Filed With SEC on April 16, 2019)
- Form of Placement Agent Warrants of Cancer Genetics, Inc (Filed With SEC on January 29, 2019)
- Form of Underwriter Warrants of Cancer Genetics, Inc (Filed With SEC on January 10, 2019)
- Offer Letter with Glenn Miles, dated November 16, 2018 (Filed With SEC on November 21, 2018)
- Engagement Letter between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC, dated as of December 3, 2017 (Filed With SEC on December 8, 2017)
- RECITALS: (Filed With SEC on November 13, 2014)
- Wells Fargo Bank, National Association (Filed With SEC on April 4, 2014)
- AMENDMENT NO. 3 TO AFFILIATION AGREEMENT (Filed With SEC on June 5, 2013)
- AMENDMENT NO. 2 TO AFFILIATION AGREEMENT (Filed With SEC on January 8, 2013)
- AMENDMENT NO. 1 TO AFFILIATION AGREEMENT (Filed With SEC on October 23, 2012)
- 900 Route 9 North Suite 301 Woodbridge, NJ 07095 phone: (732) 362-8800 fax ###-###-#### www.onyxequities.com (Filed With SEC on April 23, 2012)
- INTER-CREDITOR AGREEMENT CANCER GENETICS, INC. (Filed With SEC on March 13, 2012)
- AFFILIATION AGREEMENT (Filed With SEC on December 30, 2011)
- INTER-CREDITOR AGREEMENT CANCER GENETICS, INC. (Filed With SEC on December 30, 2011)
- TSG Atlanta | Boston | New York, Laura White ***@*** (Filed With SEC on December 30, 2011)
- Cancer Genetics, Inc. 201 Route 17 North, 2nd Floor Rutherford, NJ 07675 (Filed With SEC on December 30, 2011)
- MEDICAL DIRECTOR AGREEMENT (Filed With SEC on December 30, 2011)
- TSG 1230 Peachtree St. NE, 24th Floor, Atlanta, GA 30309, USA Panna Sharma, CEO & Managing Partner ***@*** CONFIDENTIAL MATERIAL -2- (Filed With SEC on December 30, 2011)
- AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on December 30, 2011)
